Back to search
Localized Breast Cancer
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Localized Breast Cancer trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Localized Breast Cancer trials you may qualify forBackground: Breast cancer is the most common cancer in US women. There are different types of breast cancers; some are aggressive and difficult to treat. Resea…
The goal of this interventional study is to to evaluate the effectiveness and acceptability of a focused upper body massage when offered after radiation treatme…
This phase II trial tests the safety and effectiveness of a dietary supplement called resistant potato starch for reducing musculoskeletal symptoms in patients…
The purpose of the study is to demonstrate superiority of Saruparib (AZD5305) relative to placebo added to a standard radiation therapy (RT) + androgen deprivat…
Germline testing for hereditary cancer syndromes is underutilized across most health care settings. Using a learning health care approach, the Genomics-enabled…
Why is this study being done? Many patients with a type of breast cancer (called HR-positive) take a medicine called Abemaciclib. While this medicine is effecti…
This phase II trial tests how well fezolinetant works in improving vasomotor symptoms (VMS) in breast cancer patients taking endocrine therapy (ET). Anti-hormon…
Prior to Amendment #7: The hypothesis of this study is that the combination of cabiralizumab and nivolumab with neoadjuvant chemotherapy will decrease tumor ass…